At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback